Article
Antisense therapies in neurological diseases
17 Nov 2021
Abstract excerpt
Advances in targeted regulation of gene expression allowed new therapeutic approaches for monogenic neurological diseases. Molecular diagnosis has paved the way to personalized medicine targeting the pathogenic roots: DNA or its RNA transcript. These antisense therapies rely on modified nucleotides sequences (single-strand DNA or RNA, both belonging to the antisense oligonucleotides family, or double-strand...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
